Track Group, Inc. TRCK
0.41 USD -0.05 (-10.87%)
At closeNov 10, 2026, 4:00 PM EST
0.46 Day range 0.46
0.17 52-week range 0.81
- YTD
- +36.67%
- 1 year
- +51.85%
News
globenewswire.com Fairmount Park Casino and Racing Announces Facility Improvements, New Racing Schedule for 2027 Track Boasts Record Numbers During 2026, Builds on Momentum for Future Track Boasts Record Numbers During 2026, Builds on Momentum for Future
seekingalpha.com Ares Capital: Performance Back On Track Ares Capital (ARCC) delivered a 2.3% NAV return in Q3, its strongest in the past year. ARCC's acquisition of MFIC adds significant portfolio diversification and is expected to be modestly accretive…
fool.com Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track? Tilray is consolidating its operations in Canada to simplify its business and achieve cost savings. The company announced new guidance for adjusted EBITDA that is slightly higher at the low end than…
seekingalpha.com Royce Micro-Cap Trust: A 7% Yield And A Track Record Worth Paying For Royce Micro-Cap Trust offers a nearly 7% annualized distribution yield, providing shareholders with regular quarterly payments. RMT has beaten its small-cap benchmarks over the past 5 and 10 years,…
seekingalpha.com Vishay Intertechnology Still On Track, But The Sector Has Cooled Vishay Intertechnology delivered strong Q3 results, beating expectations on revenue, margins, and free cash flow despite sector-wide sentiment headwinds. VSH is ahead of schedule on its margin…
globenewswire.com B2Gold Reports Q3 2026 Results - Lowers Annual All-In Sustaining Cost Guidance and Remains On-Track to Achieve Production Guidance VANCOUVER, British Columbia, Nov. 04, 2026 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce its operational and financial…
globenewswire.com Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile WAKIX ® Net Revenue in Q3 of $269 Million; Driven by Strong Demand with 400 Net Patient Adds in the Quarter; Reiterates Full Year Guidance of $1.0B to $1.04B
seekingalpha.com Amazon: AWS Is On Track To Outperform Today's Entire Company By 2028 Amazon (AMZN) delivered record operating profit, yet shares dipped on negative free cash flow and a shift from net cash to net debt. AWS is projected to out-earn Amazon's current total operating…